Cramer’s 10 things to watch in the market Tuesday : Dow, iPhones, JNJ

My top 10 things to watch Tuesday, January 31st

1. Will the outperformance of speculative stocks continue? The market’s worst performers of 2022 — including crypto, SPACs and cloud software stocks — are among the biggest winners in this year’s rally. stay away As I wrote on Sunday, I see this as a moment to turn to mature stocks that are in line with the so-called old, or real, economy.

Also Read :  Nikkei 225 falls more than 2% after Bank of Japan widens yield target range, yen strengthens

2. You’ll find many of these real economy stocks, or workhorses, in the Dow. We looked at its 30 members to show how they correspond to the names we hold in the Trust.

3. UBS says iPhone sell-through, or sales to end users, fell 12% in the fourth quarter of 2022 due to supply chain disruption; it maintained a buy rating on appeal (AAPL). Let’s assume that’s now consensus, which would put the stock at around $130.

4. Apple is one of 9 Club stocks to report quarterly earnings this Thursday. The list includes industrial conglomerate Honeywell International (HON), Starbucks (SBUX) and tech giant Alphabet (GOOGL). These reports and conference calls should provide good information on the state of the US economy. Here’s our breakdown of Thursday’s schedule, including analysts’ estimates for earnings per share and revenue.

5. McDonald’s (MCD) posted very good numbers – beating earnings and revenue estimates. But the market doesn’t like it, which is stupid. Shares fell more than 1% in the premarket.

6. Johnson and Johnson (JNJ) won’t be able to use the bankruptcy trick to drop tens of thousands of lawsuits over its talc products. A US appeals court has ruled that the healthcare conglomerate improperly placed a subsidiary in Chapter 11 even though it is not in financial distress. Stay a mess. The company has already paid $3 billion.

Also Read :  JLL Capital Markets closes $47 million sale of 36-building, 114-unit portfolio located in East Boston, MA : NEREJ

7. Humira’s days as the best-selling drug end today as Amgen ( AMGN ) begins selling a nearly identical biologic. AbbVie (ABBV), which makes the injectable treatment for rheumatoid arthritis, expects a 45% drop in sales in 2023. It’s mostly priced into the stock, which sells at a low multiple.

8. Caterpillars (CAT) sales rose 20% in the fourth quarter of 2022 due to strong demand for its construction equipment. It’s a really great quarter, but stocks are being treated badly by the market.

9. Deutsche Bank oversees the improvement of leadership and efficiency Disney (THIS). New CEO Robert Iger will use his own plan will better integrate Hulu.

10. The amazing decline in natural gas is something to celebrate as it is used in many things. Prices fell to their lowest level in nearly two years on Monday, thanks to an unseasonably warm winter.

(See here (for a complete list of the shares in Jim Cramer’s Charitable Trust.)

As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a share in his charitable trust’s portfolio. If Jim talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade.

THE ABOVE INVESTMENT CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY, ALONG WITH OUR DISCLAIMER. NO FIDUCIARY OBLIGATION OR DUTY EXISTS OR IS CREATED BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTMENT CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.

Source

Leave a Reply

Your email address will not be published.

Related Articles

Back to top button